Catalog Number 195-100 |
Device Problem
Use of Device Problem (1670)
|
Patient Problems
Pain (1994); Burning Sensation (2146)
|
Event Date 08/03/2022 |
Event Type
Injury
|
Event Description
|
The consumer reported having a severe allergic reaction to foamtech medical nasal swab from binaxnow covid-19 ag home test.The patient reported a very painful reaction upon inserting the swab into their nose.The patient reportedly experienced a tingling feeling that developed into an intense burning sensation in the throat.Intense additionally, the pain caused the patient to heave.The patient reportedly went to the emergency room after completing the test.The patient had no known allergies and did not conduct any allergic testing.The patient reportedly uses a nasal spray daily.Although requested, details of the emergency room visit were not provided.
|
|
Manufacturer Narrative
|
This report is being submitted for the initial and investigation completion.Technical services advised the customer to seek medical attention if the allergic reaction proceeds.Technical services emailed the customer the foamtech medical safety data sheet.Technical services provided the customer the detailed methodology for the sterilization processes of the kit swabs.The reported health status is anticipated in nature and severity for binaxnow covid-19 ag card risk documentation.
|
|
Manufacturer Narrative
|
This supplemental report is being submitted to provide the updated emergency room information and investigation conclusion.The reported health status is anticipated in nature and severity for binaxnow covid-19 ag card risk documentation.Technical services advised the customer to seek medical attention if the allergic reaction proceeds.Technical services emailed the customer the foamtech medical safety data sheet.Technical services provided the customer the detailed methodology for the sterilization processes of the kit swabs.The current overall incident rate for side effect/reaction to the sample collection for this specific kit lot and swab lot based on the total distributed devices is (b)(4).A supplemental report will be provided if any additional is obtained.The product will continue to be monitored and tracked.
|
|
Event Description
|
The emergency room diagnosed the patient with dyspnea from the test swab.The consumer was treated with an epinephrine injection.
|
|
Search Alerts/Recalls
|